Skip to main content
Figure 5 | BMC Gastroenterology

Figure 5

From: Complete response for advanced liver cancer during sorafenib therapy: Case Report

Figure 5

Twelve-months follow up with MRI before and after after injection of Primovist: 6a, arterial phase; 6b portal venous phase; 6c portal venous phase delayed; 6d hepatobiliary phase. On post contrastographic dynamic study, there is no focal enhancement on arterial phase 6a, nor signs of portal branches invasion on portal venous phase 6b, nor areas of hypointensity on delayed phase 6c. On hepatobiliary phase 6d, homogeneous enhancement of the previous neoplastic parenchyma of segment III is now appreciable.

Back to article page